Mohanad Al‐Obaidi

Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial

George R. Thompson, Àlex Soriano, Oliver A. Cornely et al. · The Lancet · 2022 · 150 citations · Full text

Translational Medicine, Antifungal Agent, Antifungal Agents +6

The Prevention of COVID-19 in High-Risk Patients Using Tixagevimab–Cilgavimab (Evusheld): Real-World Experience at a Large Academic Center

Mohanad Al‐Obaidi, Ahmet B. Gungor, Sandra Kurtin et al. · The American Journal of Medicine · 2022 · 47 citations · Full text

Vaccination, Preventive Medicine, Large Academic Center +9

Seroprevalence of Strongyloides stercoralis and Evaluation of Universal Screening in Kidney Transplant Candidates: A Single-Center Experience in Houston (2012–2017)

Mohanad Al‐Obaidi, Rodrigo Hasbun, Karen J. Vigil et al. · Open Forum Infectious Diseases · 2019 · 29 citations · Full text

Effectiveness of Casirivimab-Imdevimab Monoclonal Antibody Treatment Among High-Risk Patients With Severe Acute Respiratory Syndrome Coronavirus 2 B.1.617.2 (Delta Variant) Infection

Mohanad Al‐Obaidi, Ahmet B. Gungor, Saman Nematollahi et al. · Open Forum Infectious Diseases · 2022 · 15 citations · Full text

The Impact of Nirmatrelvir-Ritonavir in Reducing Hospitalizations Among High-Risk Patients With SARS-CoV-2 During the Omicron Predominant Era

Mohanad Al‐Obaidi, Ahmet B. Gungor, Sangeetha Murugapandian et al. · The American Journal of Medicine · 2023 · 13 citations · Full text

Reducing Hospitalizations, Patient Safety, Antiviral Therapy +8